This inventor holds 1 USPTO granted patent. Top assignee: Instytut Farmaceutyczny. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Anna Tylki-Szymanska: Innovator in Mucopolysaccharidosis Treatment
Introduction
Anna Tylki-Szymanska is a notable inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mucopolysaccharidoses. Her innovative approach has led to the development of a unique method that utilizes natural isoflavones for therapeutic purposes.
Latest Patents
Anna holds a patent for her invention titled "Isoflavones for treating mucopolysaccharidoses." This patent describes a method of treatment that involves administering a therapeutically effective amount of a natural isoflavone, its derivatives, or pharmaceutically acceptable salts to patients in need. The pharmaceutical composition includes a suitable excipient along with the isoflavone, ensuring its effectiveness in treating mucopolysaccharidosis.
Career Highlights
Anna Tylki-Szymanska is affiliated with the Instytut Farmaceutyczny, where she continues her research and development efforts. Her work has garnered attention for its potential impact on patients suffering from mucopolysaccharidoses, a group of rare genetic disorders.
Collaborations
Some of her notable coworkers include Grzegorz Grynkiewicz and Grzegorz Wegrzyn, who contribute to her research endeavors and support her innovative projects.
Conclusion
Anna Tylki-Szymanska exemplifies the spirit of innovation in the pharmaceutical industry. Her work on isoflavones for treating mucopolysaccharidoses showcases her commitment to improving patient outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile